Copyright and License Policy for JHD
Open licensing expands reuse while preserving author attribution and rights in hereditary disease publications.
Copyright Retention and Publishing License
JHD authors retain copyright and grant publication rights to the journal.
Upon acceptance, authors grant JHD the right to publish, distribute, and archive the final article while retaining copyright ownership. This model supports broad dissemination and preserves author control over attribution and reuse context.
Published articles may be shared by authors in repositories, academic profiles, and institutional pages as long as the final citation and DOI are included. This improves access for clinicians and researchers working in hereditary medicine.
Selecting a Creative Commons Route
Authors should select licenses that match funder obligations and reuse goals.
CC BY 4.0
Allows broad reuse and adaptation with attribution; commonly required by major funders.
CC BY-NC
Allows non-commercial reuse with attribution; commercial reuse requires additional permission.
CC BY-SA
Requires derivatives to use the same license when shared publicly.
CC BY-ND
Permits redistribution with attribution but does not allow adapted versions.
If your project is funded by organizations with open access mandates, confirm required license type before final acceptance. Early selection avoids production delays and compliance issues.
License choice should be declared clearly during submission and may be reconfirmed at proof stage.
Attribution and Third-Party Permissions
Reuse rights depend on license terms and source ownership.
All reuse must include attribution details: author names, article title, journal name, publication year, and DOI. Adaptations should state that changes were made and preserve traceability to the original research record.
If figures, tables, or data from third-party sources are included, authors must secure written permission and ensure reuse terms are compatible with the chosen publication license.
For clinical images or patient-derived material, confirm that consent and legal permissions cover publication and downstream reuse pathways.
How to Prevent Licensing Delays
A structured process helps authors meet institutional and funder requirements.
Check Requirements
Review funder and institutional policy before submission.
Declare License
Select and record license choice in submission documents.
Verify Permissions
Collect approvals for all third-party or restricted materials.
Confirm at Proof
Validate final license statement before publication release.
Keep permission records and license confirmations with project documentation. This simplifies future audit requests and reuse inquiries.
For licensing questions, contact [email protected] with manuscript ID and proposed reuse scenario.
License Selection at Submission Time
Early license clarity prevents production-stage delays.
Declare your preferred license in initial submission materials and confirm it again at proof stage. If funder rules require CC BY, indicate this explicitly to avoid downstream rework. Where co-authors are funded by different agencies, align license choice before acceptance so publication terms remain compliant for all parties.
For reused diagrams or clinical assets, keep permission documentation ready for editorial verification.
How Reuse Requests Are Interpreted
License terms drive reuse boundaries for educational, clinical, and commercial contexts.
Check License
Confirm whether adaptation or commercial reuse is permitted.
Apply Attribution
Include full citation metadata and DOI link in reused material.
Declare Changes
Indicate modifications for adapted figures or derivative resources.
Verify Permissions
For third-party elements, confirm rights-holder approval before reuse.
When uncertainty remains, authors or requestors should contact [email protected] with article citation and intended reuse context.
Keep Permission Documentation
Strong records simplify reuse and compliance checks.
Retain license confirmations, rights-holder approvals, and reuse notes for third-party materials. These records support audit requests and future derivative use decisions.
Clear documentation reduces legal ambiguity for both authors and downstream users.
Align License With Funding Terms
Early confirmation avoids production-stage rework.
Check grant or institutional mandates before final acceptance. If specific open licensing is required, declare it explicitly in submission records.
Use Complete Citation Metadata
Complete citations preserve scholarly traceability.
Always include DOI, journal name, year, and author list when reusing licensed JHD material.
Publish With Clear Reuse Rights
Choose a license that balances accessibility, compliance, and responsible use of hereditary disease research.
For support: [email protected]
